Skip to content

Clinical trials

Phase 2 Amyloidosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Amyloidosis Phase: Phase 2 Clear all

45 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20052
20061
20082
20091
20102
20111
20122
20132
20142
20165
20172
20182
20193
20201
20213
20223
20232
20241
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Terminated6
Recruiting4
Active, not recruiting4
Withdrawn4
Unknown status2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Brigham and Women's Hospital3
Mayo Clinic3
Fondazione IRCCS Policlinico San Matteo di Pavia2
GlaxoSmithKline2
Peking Union Medical College Hospital2
Tufts Medical Center2
Attralus, Inc.1
Boston Medical Center1
Boston University1
Chang Gung Memorial Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Amyloidosis45
Immunoglobulin Light-chain Amyloidosis10
Multiple Myeloma7
Alzheimer Disease6
Paraproteinemias3
Amyloid Neuropathies, Familial2
Cardiomyopathies2
Hematologic Neoplasms2
Polyneuropathies2
Amyloidosis, Familial1

Trials

Showing 76 to 45 of 45. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.